|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
11 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Share-based compensation expense | |||||
| Gain on change in fair value of SAFE and warrant liabilities | |||||
| Loss on change in fair value of the Brookfield Loan | |||||
| Gain on change in fair value of the Amended Brookfield Loan | |||||
| Loss on change in fair value of the FPA Put Option and the Fixed Maturity Consideration liabilities | |||||
| Change in fair value of Convertible Note | |||||
| Gain on change in fair value of PIPE Warrant liability | |||||
| Loss on change in fair value of Convertible Note | |||||
| Gain on partial lease termination | |||||
| Provisions for losses on trade and other receivables and contract assets, net of recoveries | |||||
| Depreciation of property, plant and equipment | |||||
| Amortization of discount on debt security investment | |||||
| Non-cash lease expense | |||||
| Non-cash recognition of licensing revenue | |||||
| Loss from equity method investees, net | |||||
| Loss from disposal of property, plant and equipment | |||||
| Net foreign exchange loss | |||||
| Unrealized Loss on net foreign exchange | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Contract assets | |||||
| Accrued interest on debt investment | |||||
| Other assets | |||||
| Accounts payable and accrued salaries and wages | |||||
| Contract liabilities | |||||
| Operating lease liabilities | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash Flows From Investing Activities: | |||||
| Purchase of property, plant and equipment | |||||
| Proceeds from disposal of property, plant and equipment | |||||
| Purchase of debt securities | |||||
| Proceeds from maturity of debt securities | |||||
| Purchase of additional interest in equity method investment | |||||
| Origination of related party loan | |||||
| Net cash provided by investing activities | |||||
| Cash Flows From Financing Activities: | |||||
| Proceeds from issue of equity instruments of the Company | |||||
| Proceeds from the Business Combination and PIPE, net of transaction expenses | |||||
| FPA prepayment | |||||
| Proceeds from issuance of preferred stock | |||||
| Issuance costs related to preferred stock | |||||
| Settlement of FPA | |||||
| Proceeds from exercise of options | |||||
| Proceeds from issuance of Convertible Note, net | |||||
| Repurchase of equity instruments of the Company | |||||
| Partial settlement of the Brookfield Loan | |||||
| Proceeds from PIPE Warrant | |||||
| Net cash provided by financing activities | |||||
| Effects of currency translation on cash, cash equivalents and restricted cash | |||||
| Net decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Acquisition of property, plant and equipment under accounts payable | |||||
| Receipt of common shares as payment for option exercises | |||||
| Right-of-use asset additions | |||||
| Extinguishment of the Brookfield SAFE | |||||
| Issuance of the Brookfield Loan | |||||
| Extinguishment of the Brookfield Loan | |||||
| Issuance of the Amended Brookfield Loan | |||||
| Cashless issuance of equity for Convertible Notes | |||||
| Non-cash change in lease liability on partial termination | |||||
| Non-cash change in ROU assets on partial termination | |||||
| Non-cash partial reversal of FPA upon settlement | |||||
| Third-party issuance costs for the Convertible Note | |||||
| Reclassification of capitalized costs related to the business combination to equity | |||||
| Cashless conversion of warrants on preferred shares | |||||
| Recognition of public and private warrant liabilities in the Business Combination | |||||
| Reclassification of AM SAFE warrant to equity | |||||
| Conversion of AM SAFE liability into common stock | |||||
| Conversion of Legacy LanzaTech NZ, Inc. preferred stock and in-kind dividend into common stock | |||||
| Reclassification of Shortfall warrant to equity | |||||
| Reclassification of FPA Warrants to equity | |||||
Loading...